181 related articles for article (PubMed ID: 23798614)
1. Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.
Giordano A; Gao H; Cohen EN; Anfossi S; Khoury J; Hess K; Krishnamurthy S; Tin S; Cristofanilli M; Hortobagyi GN; Woodward WA; Lucci A; Reuben JM
Ann Oncol; 2013 Oct; 24(10):2515-2521. PubMed ID: 23798614
[TBL] [Abstract][Full Text] [Related]
2. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
Reuben JM; Lee BN; Gao H; Cohen EN; Mego M; Giordano A; Wang X; Lodhi A; Krishnamurthy S; Hortobagyi GN; Cristofanilli M; Lucci A; Woodward WA
Eur J Cancer; 2011 Jul; 47(10):1527-36. PubMed ID: 21334874
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
4. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Bane A; Viloria-Petit A; Pinnaduwage D; Mulligan AM; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2013 Jul; 140(1):195-205. PubMed ID: 23813303
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
6. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
7. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
Kim WG; Lee J
Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of
Strati A; Nikolaou M; Georgoulias V; Lianidou ES
Cells; 2019 Jun; 8(7):. PubMed ID: 31261917
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations.
Alvarez-Elizondo MB; Weihs D
Cell Mol Life Sci; 2022 Feb; 79(3):134. PubMed ID: 35171381
[TBL] [Abstract][Full Text] [Related]
10. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
13. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
14. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
Lee HE; Kim JH; Kim YJ; Choi SY; Kim SW; Kang E; Chung IY; Kim IA; Kim EJ; Choi Y; Ryu HS; Park SY
Br J Cancer; 2011 May; 104(11):1730-8. PubMed ID: 21559013
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
16. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
17. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Vesuna F; Lisok A; Kimble B; Raman V
Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells and their implication in breast cancer.
Carrasco E; Alvarez PJ; Prados J; Melguizo C; Rama AR; Aránega A; Rodríguez-Serrano F
Eur J Clin Invest; 2014 Jul; 44(7):678-87. PubMed ID: 24766664
[TBL] [Abstract][Full Text] [Related]
19. Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis.
Wei W; Hu H; Tan H; Chow LW; Yip AY; Loo WT
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S6. PubMed ID: 23046710
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]